India’s Covid Boost? SII seeks DCGI approval for Covishield booster dose

Must read

Best Deals

Shivang Singh
The best way to predict the future is to create it.

New Delhi: India is aggressively reaching its goal of vaccinating the entire adult population against Covid-19, the conversation is about a booster or additional doses to be administered.

Take a step in this direction The Serum Institute of India (SII) has requested approval from the Drugs Controller General of India (DCGI) for Covishield as a booster dose.

In a request to DCGI, SII cites that there is currently a sufficient stock of covid vaccine in the country and that there is a demand for a vaccine booster due to the emergence of new coronavirus variants.

Prakash Kumar Singh, director of government and regulatory affairs at SII, says that “the UK Medicines and Health Products Regulatory Agency has already approved the booster dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine.”

“The people of our country, as well as the citizens of other countries who have already been fully vaccinated with two doses of Covishield, are also constantly asking our company for a booster dose,” PTI said quoting Singh in the app on Tuesday.

According to the PTI, SII’s request to the DGCI indicates “that as the world continues to deal with the pandemic situation, many countries have started to give a booster dose of COVID-19 vaccines”.

The Union Government has informed Parliament that the National Technical Advisory Group on Immunization and the National Expert Group on Vaccine Administration for COVID-19 are deliberating and considering scientific evidence of the need and rationale for a booster dose.

Meanwhile, the Delhi High Court on November 25 ordered the Center to clarify its position on giving booster doses to those who are fully vaccinated against the coronavirus.


- Advertisement -

More articles


Please enter your comment!
Please enter your name here

- Advertisement -

Latest article

Recommended Deal